4
Changes in Ownership
Celldex Therapeutics, Inc. Filed Acc 0001415889-23-010041
Options or other derivatives
- EXECUTIVE VP & CSO acquired 92,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| KELER TIBOR EXECUTIVE VP & CSO | 2023-06-15 | Grant or award · Incentive Stock Option (right to buy) | +92,000 | 92,000 | D | ||
Loading xslF345X04/form4-06202023_080658.xml…